日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Roadmap for the Emerging Field of Cancer Neuroscience

癌症神经科学新兴领域的发展路线图

Monje, Michelle; Borniger, Jeremy C; D'Silva, Nisha J; Deneen, Benjamin; Dirks, Peter B; Fattahi, Faranak; Frenette, Paul S; Garzia, Livia; Gutmann, David H; Hanahan, Douglas; Hervey-Jumper, Shawn L; Hondermarck, Hubert; Hurov, Jonathan B; Kepecs, Adam; Knox, Sarah M; Lloyd, Alison C; Magnon, Claire; Saloman, Jami L; Segal, Rosalind A; Sloan, Erica K; Sun, Xin; Taylor, Michael D; Tracey, Kevin J; Trotman, Lloyd C; Tuveson, David A; Wang, Timothy C; White, Ruth A; Winkler, Frank

Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.

Par-1a/MARK3/C-TAK1 激酶的缺失会导致脂肪减少、肝脂肪变性抵抗和糖异生缺陷

Lennerz Jochen K, Hurov Jonathan B, White Lynn S, Lewandowski Katherine T, Prior Julie L, Planer G James, Gereau Robert W 4th, Piwnica-Worms David, Schmidt Robert E, Piwnica-Worms Helen